The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

Penn cell therapy spinout Verismo Therapeutics has a new owner. Here's how the deal came together and why everyone is telling ...

Jaswant Kaur finds permanent relief from heart condition through successful Radiofrequency Catheter Ablation at NIMS ...

Located near Chikkaballapur in Karnataka’s capital Bengaluru, this state of the art hospital provides free treatment for any ...

HBM Healthcare Investments AG / Key word (s): Quarter Results HBM Healthcare Investments reports a compelling 15 percent increase in NAV in the 2024 calendar year 03-Jan-2025 / 17:48 CET/CEST Release ...

The IPO is entirely an OFS, the company will not receive any funds from the issue and the proceeds will go to the selling ...

Indian contract drugmaker Anthem Biosciences filed for a 33.95-billion-rupee ($397 million) initial public offering, ...

Anthem, whose services include early-stage drug discovery and drug efficacy testing, said private equity firm True North and drugmaker DavosPharma are among investors who will sell shares in the IPO.

Solar geoengineering could cool the planet and save lives from heat-related deaths. It reflects sunlight using particles but ...

This is to inform that pursuant to company code for insider trading and SEBI (PIT) Regulation, 2015, the trading window for dealing in securities for the company will remain closed from 1 January, ...

What's Sai Life Sciences Ltd share price today. Get Sai Life Sciences Ltd latest news on BSE/NSE stock price live updates, Sai Life Sciences Ltd financial results and overview, Sai Life Sciences Ltd ...